3M reports second-quarter earnings on Friday. Wall Street is looking for earnings per share of $2.01 from sales of $6.1 billion.

The Wall Street Journal reported Thursday that Union Pacific was considering a buyout of Norfolk Southern.

Lucid soars after announcing a self-driving partnership with Uber Technologies and Nuro, Taiwan Semiconductor Manufacturing reports a record profit in the second quarter, and PepsiCo’s adjusted earnings top forecasts.

Taiwan Semiconductor Manufacturing reported a 61% rise in quarterly profit as it benefits from demand for artificial-intelligence processors.

With Tesla stock stuck recently, investor attention turns to next week’s earnings report.

Nvidia was gaining after key partner Taiwan Semiconductor Manufacturing gave an upbeat outlook on artificial-intelligence processor demand.

ARKK is up 34% year to date, powered by stocks like Coinbase, Robinhood and Roku.

The Senate already passed the bill in June, and the White House on Thursday said President Donald Trump will sign it into law as soon as Friday.

Stocks could do better than skeptics fear, but not as well as the optimists are penciling in.

The government is retrenching on infrastructure spending and corporate earnings expectations are down. But a retail frenzy has kept valuations rich.

It’s a good time to consider active funds with flexible mandates to play offense and defense amid uncertainty about the macroeconomic environment.

Markets are oddly sanguine as tariff risks mount.

The index trades at just over 22 times analysts’ expected earnings, in aggregate. That may seem expensive, but not when considering Big Tech.

The pharma company said it would lay off a third of its workforce and add a black-box warning to its controversial gene therapy Elevidys.

The company says it also will make crypto trading available in other markets later this year, though it didn’t specify where.

Abbott Laboratories stock falls even as the company reports second-quarter sales that top expectations.

The company’s lack of improvement in an uncertain macro is cause for concern, Jefferies analysts say.

The health insurer now expects 2025 earnings of just $30 a share, citing ongoing and industry-wide impact of elevated cost trends in ACA and Medicaid.

The property and casualty insurer reports core earnings of $6.51 a share for the second quarter.

A number of factors, including a lack of significant gains in auto prices, are masking the extent of the shift.